NCT02499328 2026-02-11Study to Assess MEDI4736 With Either AZD9150 or AZD5069 in Advanced Solid Tumors & Relapsed Metastatic Squamous Cell Carcinoma of Head & NeckAstraZenecaPhase 1/2 Completed340 enrolled 53 charts
NCT03794544 2022-02-24Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung CancerMedImmune LLCPhase 2 Completed84 enrolled 17 charts
NCT01839604 2017-03-06A Phase I/Ib Study of AZD9150 (ISIS-STAT3Rx) in Patients With Advanced/Metastatic Hepatocellular CarcinomaAstraZenecaPhase 1 Completed58 enrolled 13 charts